Pioneering The Next
Generation 
Of Targeted
Psychoative Medications

  • SOCIAL ICONS – 6
  • SOCIAL ICONS – 7
  • SOCIAL ICONS – 5
  • SOCIAL ICONS – 9
  • SOCIAL ICONS – 8
Artboard – 2_2x.png

3 Primary Breakthroughs For The Treatment Of Mental Health Issues.

01.

Discovered an efficient, patent-pending bacterial biosynthesis process for tryptamine production.

02.

Developing a portfolio of tryptamine-derived, psychedelically inspired molecules.

03.

Demonstrated the entourage effect of certain tryptamines in a laboratory-controlled environment.

Artboard – 4_2x.png

Paradigm Shift For Treating Mental Illness and Neurological Disorders

PsyBio Therapeutics is developing biosynthetic psychoactive compounds which offer a new paradigm of treatment to reverse the course of mental health issues.

Artboard – 5_2x.png

PsyBio’s Objective Is to Develop Ground-Breaking Patient Treatments Based Upon Psychedelic Agents

PsyBio Therapeutics is creating a portfolio of unique, scientifically developed, psychoactive compounds as potential therapeutic agents for mental and neurologic health issues and developing an efficient, patent-pending bacterial biosynthesis process for tryptamine production with platform technology utilizing metabolic engineering and optimization techniques.

Bullet_2x.png

Research & Development Partners

Artboard – 7_2x.png

Psybio Has World Class Team Of Leaders and Experts

Bullet_2x.png

Experienced CEO with over 25 years in the Biotech Industry

Bullet_2x.png

Chief Medical Officer with Expanded Clinical Trial and Regulatory Experienc

Management is key to a successful biotechnology company in obtaining FDA approval for its leading therapeutic candidates.

Bullet_2x.png

Excellent Board of Directors

Send Us a Message

 

Investor Inquiries